| Risk factors and biomarkers for immune-related adverse events: a practical guide to identifying high-risk patients and rechallenging immune checkpoint inhibitors A Chennamadhavuni, L Abushahin, N Jin, CJ Presley, A Manne Frontiers in immunology 13, 779691, 2022 | 214 | 2022 |
| Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer T Jiang, BJ Collins, N Jin, DN Watkins, MV Brock, W Matsui, BD Nelkin, ... Cancer research 69 (3), 845-854, 2009 | 212 | 2009 |
| Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling EK Nakakura, VR Sriuranpong, M Kunnimalaiyaan, EC Hsiao, ... The Journal of Clinical Endocrinology & Metabolism 90 (7), 4350-4356, 2005 | 139 | 2005 |
| Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 DW Ball, N Jin, DM Rosen, A Dackiw, D Sidransky, M Xing, BD Nelkin The Journal of Clinical Endocrinology & Metabolism 92 (12), 4712-4718, 2007 | 112 | 2007 |
| Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancer N Jin, T Jiang, DM Rosen, BD Nelkin, DW Ball Clinical Cancer Research 17 (20), 6482-6489, 2011 | 109 | 2011 |
| Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancer N Jin, T Jiang, DM Rosen, BD Nelkin, DW Ball The Journal of Clinical Endocrinology & Metabolism 94 (10), 4107-4112, 2009 | 91 | 2009 |
| Advances in epigenetic therapeutics with focus on solid tumors N Jin, TL George, GA Otterson, C Verschraegen, H Wen, D Carbone, ... Clinical epigenetics 13, 1-27, 2021 | 84 | 2021 |
| Paclitaxel induces micronucleation and activates pro-inflammatory cGAS–STING signaling in triple-negative breast cancer Y Hu, BK Manasrah, SM McGregor, RF Lera, RX Norman, JB Tucker, ... Molecular cancer therapeutics 20 (12), 2553-2567, 2021 | 57 | 2021 |
| Mechanisms of immunosuppression in colorectal cancer Y Zhang, A Rajput, N Jin, J Wang Cancers 12 (12), 3850, 2020 | 51 | 2020 |
| Neoadjuvant chemotherapy for colorectal liver metastases: a contemporary review of the literature M Guo, N Jin, T Pawlik, JM Cloyd World Journal of Gastrointestinal Oncology 13 (9), 1043, 2021 | 39 | 2021 |
| The application of metabolomics in recent colorectal cancer studies: a state-of-the-art review A Gold, F Choueiry, N Jin, X Mo, J Zhu Cancers 14 (3), 725, 2022 | 37 | 2022 |
| Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake ML Ramsey, J Tomlinson, R Pearlman, L Abushahin, A Aeilts, HZ Chen, ... Familial cancer 22 (1), 91-97, 2023 | 25 | 2023 |
| Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer DW Ball, N Jin, P Xue, S Bhan, SR Ahmed, DM Rosen, A Schayowitz, ... Oncology reports 34 (5), 2319-2324, 2015 | 22 | 2015 |
| Polymerase epsilon-associated ultramutagenesis in cancer XX Xing, N Jin, J Wang Cancers 14 (6), 1467, 2022 | 17 | 2022 |
| Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high‐risk localized prostate cancer M Yin, J Zhao, P Monk, D Martin, E Folefac, M Joshi, N Jin, A Mortazavi, ... Cancer medicine 9 (1), 27-34, 2020 | 14 | 2020 |
| Chromosomal instability upregulates interferon in acute myeloid leukemia N Jin, RF Lera, RE Yan, F Guo, K Oxendine, VL Horner, Y Hu, J Wan, ... Genes, Chromosomes and Cancer 59 (11), 627-638, 2020 | 12 | 2020 |
| Exogenous Sequences in Tumors and Immune Cells (Exotic): A Tool for Estimating the Microbe Abundances in Tumor RNA-seq Data R Hoyd, CE Wheeler, YZ Liu, MS Jagjit Singh, M Muniak, N Jin, ... Cancer Research Communications 3 (11), 2375-2385, 2023 | 8 | 2023 |
| MACROD2, an Original Cause of CIN? N Jin, ME Burkard Cancer discovery 8 (8), 921-923, 2018 | 7 | 2018 |
| Stage I squamous cell carcinoma of the anus: is radiation therapy alone sufficient treatment? E Miller, A Nalin, D Diaz Pardo, A Arnett, L Abushahin, S Husain, N Jin, ... Cancers 12 (11), 3248, 2020 | 6 | 2020 |
| Microbiome signature, global methylation and immune landscape in early onset colorectal cancer. N Jin, X Mo, R Hoyd, AS Yilmaz, YZ Liu, M Jagjit Singh, M Muniak, ... Journal of Clinical Oncology 39 (15_suppl), 3519-3519, 2021 | 4 | 2021 |